Skip to content
Clinical Trials – home
Therapeutic area

Injury, poisoning and procedural complications – page 19

  • 286 clinical trials
  • 125 recruiting
  • 217 conditions
  • 25 countries

Conditions in this area

217 conditions with trials, the busiest first

Clinical trials in Injury, poisoning and procedural complications

286 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

286 clinical trials

Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Itolizumab
  • Sponsor:Equillium Inc.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Capsaicin
  • Sponsor:Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Medical University Of Graz
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Axatilimab
  • Sponsor:Incyte Corp.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Autologous T Regulatory Cells Expressing An Hla-A2-Specific Chimeric Antigen Receptor
  • Sponsor:Quell Therapeutics Limited
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Glepaglutide
  • Sponsor:Zealand Pharma A/S
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Panobinostat
  • Sponsor:Novartis Pharma Services AG
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Epinephrine
  • Sponsor:Region Hovedstaden
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Ropivacaine Hydrochloride
  • Sponsor:Pirkanmaan hyvinvointialue
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Imlifidase
  • Sponsor:Hansa Biopharma AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:DKMS Group gGmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Allogeneic Cd4+ And Cd25+ T Lymphocytes Ex Vivo Incubated With Gp120
  • Sponsor:ActiTrexx GmbH

Substances studied in this area

The therapies tested most often in Injury, poisoning and procedural complications trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.